:::

詳目顯示

回上一頁
題名:The Prevalence and Characteristics of Obesity among Inpatients with Schizophrenia in Taiwan
書刊名:Taiwanese Journal of Psychiatry
作者:吳孟寰景瀚儀吳聖良張介信陳俊鶯張達人
作者(外文):Wu, Meng-huanChing, Han-yiWu, Shang-liangChang, Chieh-hsingChen, Chung-yingChang, Ta-jen
出版日期:2012
卷期:26:1
頁次:頁41-47+68
主題關鍵詞:精神分裂病住院病患肥胖盛行率PrevalenceObesityInpatientsSchizophrenia
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:0
  • 點閱點閱:23
目的:此文章為台灣第一篇探討精神分裂病住院病人肥胖及腹部肥胖盛行率的研究,並進一步與一般民眾及社區病人做比較。方法:研究對象為西元2010年三月期間某療養院慢性病房住院之710位精神分裂病病人。根據台灣行政院衛生署:肥胖定義為body massindex (BMI) ≥ 27,腹部肥胖定義為男性腰圍 > 90 cm,女性腰圍 > 80 cm。結果:研究對象中60%為男性,平均年齡47.6 ± 9.5歲,平均發病年齡32.7 ± 10歲,平均罹患精神分裂症時間14.9 ± 6.8年,平均住院時間4.6 ± 2.9年,肥胖盛行率為16.4%(男女分別為14.3% 和19.7%),腹部肥胖盛行率為53.8%(男女分別為39.7% 和75%)。結論:精神分裂病住院病人之腹部肥胖盛行率比一般民眾高,而女性住院病人之腹部肥胖盛行率更高達一般民眾的2.2倍。顯示台灣慢性病房精神分裂病住院病人需要更積極的腹部肥胖介入與預防措施。
Objectives: This study was intended to investigate the prevalence and characteristics of obesity and abdominal obesity among inpatients with schizophrenia, and to compare with outpatients and persons in the general population. Methods: We recruited 710 patients with schizophrenia from chronic wards in a mental hospital in Taiwan in March 2010. Obesity and abdominal obesity were defined as the body mass index (BMI) ≥ 27 as well as waist circumference > 90 cm in male, and > 80 cm in female patients, respectively, by the definition set by the Department of Health, Executive Yuan, Taiwan 2002. Results: We analyzed demographic characteristics of 710 participants, including 426 male (60%) and 284 female (40%) patients. The mean age was 47.6 ± 9.5 years and the mean age of onset of the disease was 32.7 ± 10 years. The average length of illness was 14.9 ± 6.8 years, while the mean length of hospitalization was 4.6 ± 2.9 years. The overall prevalence of obesity was 16.4%, with 14.3% in male and 19.7% in female patients, respectively. The overall prevalence of abdominal obesity was 53.8%, with 39.7% in male and 75% in female patients. Conclusion: The prevalence of abdominal obesity among schizophrenic inpatients was higher than that among persons in the general population. Female inpatients had 2.2-fold higher prevalence of abdominal obesity than persons in the general population. Therefore, we suggested that active prevention and intervention for abdominal obesity among inpatients with schizophrenia on chronic wards in Taiwan are needed.
期刊論文
1.Yeh, C.-J.、Chang, H.-Y.、Pan, W.-H.(2011)。Time trend of obesity, the metabolic syndrome and related dietary pattern in Taiwan: From NAHSIT 1993-1996 to NAHSIT 2005-2008。Asia Pacific Journal of Clinical Nutrition,20(2),292-300。  new window
2.Kurzthaler, I. K.、Fleischhaker, W. W.(2001)。The clinical implications of weight gain in schizophrenia。Journal of Clinical Psychiatric,62(Suppl. 7),32-37。  new window
3.Must, A.、Dietz, W. H.、Spandano, J.、Coakley, E. H.、Field, A. E.、Colditz, G.(1999)。The disease burden associated with overweight and obesity。Journal of the American Medical Association,282,1523-1529。  new window
4.Brown, S.、Inskip, H.、Barraclough, B.(2000)。Causes of the excess mortality of schizophrenia。British Journal of Psychiatry,177,212-217。  new window
5.Huang, M. C.、Lu, M. L.、Tsai, C. J.、Chen, P. Y.、Chiu, C. C.、Jian, D. L.、Chen, C. H.(2009)。Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan。Acta Psychiatrica Scandinavica,120,274-280。  new window
6.Allison, D. B.、Newcomer, J. W.、Dunn, A. L.、Blumenthal, J. A.、Fabricatore, A. N.、Daumit, G. L.、Cope, M. B.、Riley, W. T.、Vreeland, B.、Hibbeln, J. R.、Alpert, J. E.(2009)。Obesity among those with mental disorders: a National Institute of Mental Health meeting report。American journal of preventive medicine,36(4),341-350。  new window
7.Colton, CW、Manderscheid, RW(2006)。Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states。Prev Chronic Dis,3,A42。  new window
8.Osby, U、Correia, N、Brandt, L、Ekbom, A、Sparen, P(2000)。Mortality and causes of death in schizophrenia in Stockholm county, Sweden。Schizophr Res,29,21-28。  new window
9.Auquier, P.、Lancon, C.、Rouillon, F.、Lader, M.(2007)。Mortality in schizophrenia。Pharmacoepidemiology and Drug Safety,16(12),1308-1312。  new window
10.Oud, MJ、Jong, BM(2009)。Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care。BMC Fam Pract,10,32。  new window
11.De Hert, MA、Winkel, R、Van Eyck, D(2006)。Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication。Schizophr Res,83,87-93。  new window
12.Allison, DB、Casey, DE(2001)。Antipsychotic-induced weight gain: a review of the literature。J Clin Psychiatry,62,22-31。  new window
13.Reist, C、Mintz, J、Albers, LJ、Jamal, MM、Szabo, S、Ozdemir, V(2007)。Second-generation antipsychotic exposure and metabolic-related disorders in patients with schizophrenia: an observational pharmacoepidemiology study from 1988 to 2002。Clin Psychopharmacol,27,46-51。  new window
14.Bell, RC、Farmer, S、Ries, R、Srebnik, D(2009)。Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics。Psychiatr Serv,60,1686-1689。  new window
15.Bobes, J、Arango, C、Aranda, P、Carmena, R、Garcia-Garcia, M、Rejas, J(2007)。Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study。Schizophr Res,90,162-173。  new window
16.Coodin, S(2001)。Body mass index in persons with schizophrenia。Can J Psychiatry,46,549-555。  new window
17.Hsiao, CC、Ree, SC、Chiang, YL、Yeh, SS、Chen, CK(2004)。Obesity in schizophrenic outpatients receiving antipsychotics in Taiwan。Psychiatry Clin Neurosci,58,403-409。  new window
18.Poulin, MJ、Chaput, JP、Simard, V(2007)。Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme。Aust N Z Psychiatry,41,980-989。  new window
19.Sugawara, N、Yasui-Furukori, N、Sato, Y(2011)。Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia。Ann Gen Psychiatry,10,21。  new window
20.Hakko, H、Komulainen, M、Koponen, H(2006)。Are females at special risk of obesity if they become psychotic? the longitudinal Northern Finland 1966 Birth Cohort Study。Schizophr Res,84,15-9。  new window
21.McEvoy, J. P.、Meyer, J. M.、Goff, D. C.(2005)。Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III。Schizophr Res,80,19-32。  new window
22.Kuruvilla, A、Peedicayil, J、Srikrishna, G、Kuruvilla, K、Kanagasabapathy, AS(1992)。A study of serum prolactin in schizophrenia: comparison of males and females。Clin Exp Pharmacol Physiol,19,603-606。  new window
23.Smith, S、Wheeler, MJ、Murray, R、O’Keane, V(2002)。The effect of antipsychotic-induced hyperprolactinemia on the hypothalamic-pituitary-gonadal axis。J Clin Psychopharmacol,22,109-114。  new window
24.Wieck, A、Haddad, PM(2003)。Antipsychotic-induced hyper-prolactinaemia in women: pathophysiology, severity and consequences。Br J Psychiatry,182,199-204。  new window
25.Choi, SB、Jang, JS、Park, S(2005)。Estrogen and exercise may enhance beta-cell function and mass via IRS2 induction in ovariectomized diabetic rats。Endocrinology,146,4786-4794。  new window
26.Gerozissis, K(2008)。Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies。Eur J Pharmacol,585,38-49。  new window
27.Park, S、Sang, MH、I1, SA、Sung, HK(2010)。Olanzapine, not resperidone, exacerbates beta-cell function and mass in ovariectomized diabetic rats and estrogen replacement reverses them。J Psychopharmacol,24,1105-1114。  new window
28.Duvnjak, L、Duvnjak, M(2009)。The metabolic syndrome - an ongoing story。J Physiol Pharmacol,60,19-24。  new window
29.Taylor, T. L.、Killaspy, H.、Wright, C.(2009)。A systematic review of the international published literature relating to quality of institutional care for people with longer term mental health problems。BMC Psychiatry,9,55。  new window
30.Bigaard, J、Frederikse, K、Tjonneland, A(2005)。Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women。Int J Obes,29,778-784。  new window
31.Wei, M.、Gaskill, S. P.、Haffner, S. M.、Stern, M. P.(1997)。Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans: a 7-year prospective study。Obesity research,5(1),16-23。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE